Dr. Reddy’s Laboratories has closed the acquisition of Habitrol brand (an over-the-counter nicotine replacement therapy transdermal patch) from Novartis Consumer Health Inc following issuance of the proposed consent order from the U.S. Federal Trade Commission (FTC) on November 26, 2014.
Real Time News & Trading Trends Keep Liking #EpicResearch
Facebook – Twitter – YouTube – Pinterest –Linkedin –Google+
For more information ✆ – 0731-6642300 or Visithttp://www.epicresearch.co
No comments:
Post a Comment